Epigral Limited (BOM:543332)

Market Cap	42.16B -45.3%
Revenue (ttm)	24.19B -1.2%
Net Income	3.38B -2.9%
EPS	78.35 -5.8%
Shares Out	n/a
PE Ratio	12.48
Forward PE	14.08
Dividend	3.50 (0.36%)
Ex-Dividend Date	Jun 20, 2025

Volume	2,980
Average Volume	3,343
Open	993.05
Previous Close	1,003.75
Day's Range	971.40 - 1,003.55
52-Week Range	903.10 - 2,114.30
Beta	n/a
RSI	35.32
Earnings Date	Jan 30, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals and Allied Products
• Founded: 2007
• Employees: 1,072
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543332

Financial Performance

In fiscal year 2025, Epigral's revenue was 25.50 billion, an increase of 32.19% compared to the previous year's 19.29 billion. Earnings were 3.58 billion, an increase of 82.62%.